TOP SELLING PRODUCTS Research Benefits CJC-1295 Ipamorelin Blend is a research peptide combination composed of CJC-1295 (NO DAC) and Ipamorelin and is intended for laboratory-based investigation only
This page is educational and is not legal or medical advice
Limitation of Liability The publisher, authors, distributors, and affiliated parties disclaim all liability for any adverse outcomes, health consequences, financial losses, or other damages arising from use of information contained in this publication
Cardiovascular Issues: Changes in metabolic functions may increase the risk of hypertension and heart disease
Lower dose (~330 mcg/day): 1 vial 4 weeks 8 weeks: ~24 vials 12 weeks: ~36 vials Insulin Syringes (U-100, 1 mL) Per injection: 1 syringe 8 weeks (once daily): ~56 syringes 12 weeks (once daily): ~84 syringes Bacteriostatic Water (10 mL bottles) Use 23 mL per 10 mg blend vial for reconstitution
Researchers in Canada studying the synergistic mechanisms of GHRH analogs and GHRPs can access both compounds in a pre-blended, research-ready format from Maple Research Labs